Anaplastic Large-Cell Lymphoma: Clinical Presentation and Age Distribution
ALCL, ALK-positive occurs most commonly in children and young adults with a median age of approximately 30-35 years, while ALCL, ALK-negative typically affects older adults with a median age of 54-61 years. 123
Age Distribution by Subtype
ALK-Positive ALCL
- Median age: ~30-35 years 2
- Predominantly affects children and young adults 1
- Male predominance (male-to-female ratio varies by study) 2
- In one Chinese cohort, median age was 29 years (range 14-67) 4
ALK-Negative ALCL
- Median age: 54-61 years 3
- Affects older adult population 1
- Male-to-female ratio approximately 0.9-1.6 53
- In the International T-Cell Project, median age was 54 years (range 18-89) 5
The age difference between ALK-positive and ALK-negative subtypes is statistically significant and clinically important for differential diagnosis. 4
Clinical Presentation
Disease Stage at Presentation
- 65-71% of patients present with advanced stage III or IV disease 15
- Stage III-IV occurs in 65% of ALK-positive and 58% of ALK-negative cases 1
- Early stage (I-II) disease is uncommon but carries better prognosis 1
Common Presenting Features
Systemic symptoms are frequent:
- B symptoms (fever, night sweats, weight loss) present in 57.5-62.5% of patients 4
- Systemic symptoms frequently accompany advanced stage disease 1
Nodal and extranodal involvement:
- Lymph node involvement occurs in approximately 50% of ALK-negative cases 3
- Extranodal involvement is very common, occurring in up to 95% of patients 4
- Extranodal sites include skin, soft tissue, bone, gastrointestinal tract, and other organs 1
- Bone marrow involvement is relatively uncommon 15
- Bulky disease is uncommon 5
Laboratory Findings
- Elevated LDH in approximately 62.5% of patients 4
- High Ki-67 expression (≥80%) in about 62.5% of cases 4
Prognostic Features at Presentation
- 66% of ALK-negative patients present with low (0-1) International Prognostic Index (IPI) score 5
- Approximately 40% of ALK-positive patients are low-risk by IPI 2
- Despite advanced stage, many patients have favorable prognostic scores due to younger age and good performance status in ALK-positive disease 2
Key Diagnostic Pitfalls
Critical distinction: The hallmark cells (large cells with eccentric, horseshoe- or kidney-shaped nuclei with eosinophilic paranuclear region) are present in all cases but may be variable in proportion 2. CD30 positivity is universal and essential for diagnosis 1.
Common caveat: Primary cutaneous ALCL represents a distinct entity with different demographics and prognosis—it should be excluded through careful staging before diagnosing systemic ALCL 16.